CHF fase I BMS
A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986224 in Healthy Subjects and Chronic HFrEF
- Stage
- klaar
- Medicine
- BMS-986224
- Population
- Hartfalen
- Phase
- Ib
- First Patient In
- -
- Last Patient In
- 29 April 2019
- Last Patient Last Visit
- -
Board Contact
